Loading…
Oncolytics Biotech Inc. is projected to rise to $1.23 by 2027, a +39% move from its current price of $0.8873. ONCY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.8461 | $0.887 | $0.93 | -0.03% |
| Jul 14 | $0.8294 | $0.8868 | $0.9481 | -0.06% |
| Jul 15 | $0.8168 | $0.8865 | $0.9622 | -0.09% |
| Jul 16 | $0.8063 | $0.8863 | $0.9741 | -0.12% |
| Jul 17 | $0.7971 | $0.886 | $0.9848 | -0.15% |
| Jul 18 | $0.7889 | $0.8857 | $0.9945 | -0.17% |
| Jul 19 | $0.7814 | $0.8855 | $1.00 | -0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7814 | $0.8855 | $1.00 | -0.20% |
| Week 2 | $0.7404 | $0.8837 | $1.05 | -0.41% |
| Week 3 | $0.7101 | $0.8819 | $1.10 | -0.61% |
| Week 4 | $0.6853 | $0.8801 | $1.13 | -0.81% |
| Week 5 | $0.664 | $0.8783 | $1.16 | -1.02% |
| Week 6 | $0.6452 | $0.8765 | $1.19 | -1.22% |
| Week 7 | $0.6283 | $0.8747 | $1.22 | -1.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company that engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of GI tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer.
It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Oncolytics Biotech Inc. (ONCY) currently trades at $0.92 and has a market capitalization of $109.81M. It ranks 4181 in market cap liquidity and size. The near-term forecast for 2026 shows a min of $0.78, an avg of $0.92, and a max of $1.13, with a 0% ROI and NEUTRAL sentiment.
The 30-day price range spans from $0.6692 to $1.26, illustrating modest upside potential within a constrained trading band. The stock exhibits an annualized volatility of 90%, underscoring substantial price movement potential.
A major floor 27.5% below — a decisive break under it would weaken the trend.
The nearest floor, 11.0% below — buyers have tended to step in here.
The nearest ceiling, 19.5% above — a clean break opens room to run.
A major ceiling 33.4% above — clearing it would confirm fresh momentum.
Key ONCY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ONCY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.868 | Buy | $0.8821 | Buy |
| MA 10 | $0.90 | Sell | $0.8893 | Sell |
| MA 20 | $0.9005 | Sell | $0.8942 | Sell |
| MA 50 | $0.886 | Buy | $0.9057 | Sell |
| MA 100 | $0.9446 | Sell | $0.9314 | Sell |
| MA 200 | $1.01 | Sell | $0.9525 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.39 | Neutral |
| Stoch RSI (14) | 62.99 | Neutral |
| CCI (20) | -16.89 | Neutral |
| Williams %R (14) | -41.18 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -5.32 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 58.82 | Neutral |
| TRIX (15) | 0.04 | Buy |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 41.32 | Neutral |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 0.85 | Buy |
| ADX (14) | 10.82 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture shows NEUTRAL sentiment with an RSI of 50. The 50-day simple moving average sits at $0.8862 and the 200-day simple moving average sits at $1.01, suggesting the stock is trading between short- and longer-term averages. Key levels to watch are support at $0.79 and resistance at $1.06, with a 30-day trading range from $0.6692 to $1.26.
The annualized volatility remains high at 90%, indicating ongoing price fluctuations within the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.78 | $0.8873 | $1.10 | 0% | Neutral | |
| $0.9127 | $1.23 | $1.79 | +39% | Bullish | |
| $0.8825 | $1.25 | $1.93 | +41% | Bullish | |
| $0.854 | $1.27 | $2.04 | +43% | Bullish | |
| $0.8131 | $1.26 | $2.10 | +42% | Bullish | |
| $0.7383 | $1.18 | $2.04 | +33% | Bullish | |
| $0.8634 | $1.43 | $2.54 | +62% | Bullish | |
| $1.03 | $1.77 | $3.21 | +99% | Bullish | |
| $1.09 | $1.94 | $3.61 | +119% | Bullish | |
| $1.12 | $2.06 | $3.91 | +132% | Bullish | |
| $1.49 | $3.17 | $6.58 | +257% | Bullish | |
| $1.76 | $3.90 | $8.98 | +340% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.78 | $0.8873 | $1.07 | +0.00% |
| August 2026 | $0.6983 | $0.841 | $1.05 | -5.22% |
| September 2026 | $0.7086 | $0.864 | $1.10 | +2.74% |
| October 2026 | $0.7152 | $0.8814 | $1.14 | +2.02% |
| November 2026 | $0.6712 | $0.8347 | $1.09 | -5.30% |
| December 2026 | $0.6587 | $0.8262 | $1.10 | -1.02% |
Click any year to see its month-by-month ONCY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ONCY is projected to trade between $0.78 and $1.10, averaging $0.8873 — a potential gain of 0% from today's $0.8873. Price action looks broadly range-bound.
Oncolytics Biotech Inc.'s 2027 outlook centres on $1.23, within a $0.9127 to $1.79 range. That is up +39% on the projected 2026 average. That marks a +39% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ONCY could reach as high as $1.93, with a base case around $1.25 and support toward $0.8825 — roughly +41% from $0.8873. Momentum favours further upside here.
Expect ONCY to range from $0.854 to $2.04 through 2029. The $1.27 average target implies a +43% move from current prices. That is up +1% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ONCY price prediction for 2030 points to an average of $1.26 (low $0.8131, high $2.10) — a potential gain of +42% on today's $0.8873. Momentum favours further upside here.
In 2031, ONCY is projected to trade between $0.7383 and $2.04, averaging $1.18 — a potential gain of +33% from today's $0.8873. That is -6% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Oncolytics Biotech Inc.'s 2032 outlook centres on $1.43, within a $0.8634 to $2.54 range. That is up +21% on the projected 2031 average. That marks a +62% change versus current levels. Momentum favours further upside here.
By 2033, ONCY could reach as high as $3.21, with a base case around $1.77 and support toward $1.03 — roughly +99% from $0.8873. Buyers look set to stay in control over this stretch.
Expect ONCY to range from $1.09 to $3.61 through 2034. The $1.94 average target implies a +119% move from current prices. That is up +10% on the projected 2033 average. Momentum favours further upside here.
The ONCY price prediction for 2035 points to an average of $2.06 (low $1.12, high $3.91) — a potential gain of +132% on today's $0.8873. Buyers look set to stay in control over this stretch.
In 2040, ONCY is projected to trade between $1.49 and $6.58, averaging $3.17 — a potential gain of +257% from today's $0.8873. That is up +54% on the projected 2035 average. Momentum favours further upside here.
Oncolytics Biotech Inc.'s 2050 outlook centres on $3.90, within a $1.76 to $8.98 range. That is up +23% on the projected 2040 average. That marks a +340% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ONCY today (≈ 1,127.014538 ONCY) could be worth
$4,399.26
+$3,399.26 (+340%) by 2050 · US Dollar
Based on the average projected ONCY price of $3.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ONCYwould be worth at today's price.
$1,000 invested in ONCY on Jul 10, 2025 (≈ 892.857139 ONCY) would be worth
$792.23
-$207.77 (-20.8%) today · 0.79× · US Dollar
Based on a ONCY entry price of $1.12 vs. today's $0.8873.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.9 | $985.89 | -1.4% |
| 1 month ago | $0.8 | $1,109.12 | +10.9% |
| 3 months ago | $0.93 | $954.09 | -4.6% |
| 6 months ago | $0.99 | $896.26 | -10.4% |
| 1 year ago | $1.12 | $792.23 | -20.8% |
| All time (5.0y) ago | $2.48 | $357.78 | -64.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ONCY forecast.
Our base-case forecast reaches $1.80 around 2034.
Implied market cap at $1.80: $214.84M
The multi-year forecast points to a bullish trajectory beyond 2026, with meaningful upside in the late 2020s and into the 2030s and beyond. In 2030 the forecast shows a min of $0.8223, an average of $1.28, and a max of $2.15, representing a 39.2% ROI and a BULLISH sentiment. In 2040 the forecast shows a min of $1.44, an average of $3.14, and a max of $6.58, representing a 240.9% ROI and a BULLISH sentiment.
In 2050 the forecast shows a min of $1.71, an average of $3.81, and a max of $8.76, representing a 313.9% ROI and a BULLISH sentiment. These are estimates, not guarantees, and outcomes may vary with market conditions and company progress.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $1.28, with a min of $0.8223 and a max of $2.15, and a 39.2% ROI; sentiment is BULLISH.
The long-term outlook is bullish, with 2027 average around $1.27 and 2030 around $1.28, rising to 2040 around $3.14 and 2050 around $3.81. ROI reaches 39.2% by 2030 and 313.9% by 2050, but these are estimates.
Yes—the forecast max price reaches $2.15 in 2030, and exceeds $3 in 2033 ($3.24), $6.58 in 2040, and $8.76 in 2050.
Current price is $0.92 and market capitalization is $109.81M.
For 2026, min $0.78, avg $0.92, max $1.13 with 0% ROI and NEUTRAL sentiment. The 30-day range is from $0.6692 to $1.26, RSI is 50, SMA50 is $0.8862, SMA200 is $1.01, with support at $0.79 and resistance at $1.06. Annualized volatility is 90%.
Oncolytics Biotech Inc. Community Discussion
0Share your Oncolytics Biotech Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.